Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial

Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: وحید منتظری , بهزاد برادران , سعید پیروزپناه , ندا رضوانی

کلمات کلیدی: Benign breast disease, conjugated fatty acid, central obesity, blood pressure

نشریه: 28307 , 2S , 20 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سعید پیروزپناه
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده تغذیه
کد مقاله 65430
عنوان فارسی مقاله Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial
عنوان لاتین مقاله Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Health benefits of conjugated fatty acids, particularly conjugated linolenic acid (CLNA), have recently provide substantial insights in a variety of obesity-related tumorigenesis including breast neoplasia. This study aims to investigate the effects of CLNA-contained oil (CLNAO) supplementation on central obesity indices and blood pressure in women with benign breast disease (BBD). Methods: Forty six pre-menopausal women with BBD were randomly allocated to intervention group (n=23) or placebo (n=23). Patients in the intervention group received 1000 mg/day CLNAO capsule and the placebo group received 1000 mg/day inert oil-contained capsule during 13 weeks. Measures of blood pressure and some anthropometric variables were performed at the baseline and end of study. Result: Systolic (P<0.01) and diastolic (P<0.05) blood pressures decreased within CLNAO group on subjects whom were overweight. Normal weight participants who received placebo showed significant increases in total body fat (P<0.05), waist circumference (P<0.05), and waist circumference to height ratio (P<0.05), meantime CLNAO group showed no changes on both variables. Intervention with CLNAO caused no significant increases on skinfolds of abdomen and suprailiac, whereas these measures were remarkably increased in placebo (P<0.001 and P<0.05, respectively). Conclusion: Findings from this study show that CLNAO can attenuate development of central fat acquisition in the BBD patients who weighted normally. Administration of CLNAO decline systolic and diastolic blood pressures of overweight subjects.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
وحید منتظریدوم
بهزاد برادرانسوم
سعید پیروزپناهپنجم
ندا رضوانیاول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
5708-Article Text-19081-3-10-20181212.pdf1397/10/19610286دانلود